Fundraising Fox
Neurotherapia
Cleveland, US · Founded 2015 · 8 employees on LinkedIn · 2 known investors
Find your way into Neurotherapia
NeuroTherapia is a clinical-stage biotech company developing novel treatments for neuroinflammatory disorders, including Alzheimer's disease, neuropathic pain, multiple sclerosis, and ALS. Its lead candidate, NTRX-07, is a CB2 receptor agonist designed to reduce neuroinflammation and promote neuronal survival.
Investors · 2
Dolby Family Ventures✓ confirmed by NeurotherapiaSan Francisco
How we know: the company's own site · Dolby Family Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Neurotherapia do?
- NeuroTherapia is a clinical-stage biotech company developing novel treatments for neuroinflammatory disorders, including Alzheimer's disease, neuropathic pain, multiple sclerosis, and ALS. Its lead candidate, NTRX-07, is a CB2 receptor agonist designed to reduce neuroinflammation and promote neuronal survival.
- Who are Neurotherapia's investors?
- Neurotherapia's investors include Dolby Family Ventures, Brain Trust Accelerator Fund.
- Where is Neurotherapia headquartered?
- Neurotherapia is headquartered in Cleveland, US.